3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Neoplasms
1
Klatskin Tumor
1
Cholangiocarcinoma
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Fluorouracil
2
Capecitabine
2
tremelimumab
1
trametinib
1
temoporfin
1
durvalumab
1
dehydroftorafur
1
Sorafenib
1
Self Expandable Metallic Stents
1
Radiosurgery
1
Platinum
1
Oxaliplatin
1
N-Ac-CHAVC-NH2
1
Leucovorin
1
Hydroxychloroquine
1
Gemcitabine
1
Erlotinib Hydrochloride
1
Cisplatin
1
3-(4-chlorophenyl)-adamantane-1-carboxylic acid (pyridin-4-ylmethyl)amide
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Klatskin Tumor
×
temoporfin
×
Clear all
NCT03003065
2023-08-22
PDT
Chinese University of Hong Kong
Phase 2
Completed
10 enrolled